These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27723449)

  • 1. Selection strategies for newly registered blood donors in European countries.
    Lieshout-Krikke RW; Domanovic D; De Kort W; Mayr W; Liumbruno GM; Pupella S; Kurz J; Knutson F; Maclennan S; Folléa G
    Blood Transfus; 2017 Oct; 15(6):495-501. PubMed ID: 27723449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predonation screening of candidate donors and prevention of window period donations.
    Lieshout-Krikke RW; Zaaijer HL; van de Laar TJ
    Transfusion; 2015 Feb; 55(2):373-8. PubMed ID: 25130605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria.
    Whyte GS; Savoia HF
    Med J Aust; 1997 Jun; 166(11):584-6. PubMed ID: 9201178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
    Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
    Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.
    Soldan K; Barbara JA; Ramsay ME; Hall AJ
    Vox Sang; 2003 May; 84(4):274-86. PubMed ID: 12757501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review.
    Wu D; Feng F; Wang X; Wang D; Hu Y; Yu Y; Huang J; Wang M; Dong J; Wu Y; Zhu H; Zhu F
    BMC Infect Dis; 2022 Mar; 22(1):279. PubMed ID: 35321684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety.
    Omidkhoda A; Razi B; Arabkhazaeli A; Amini Kafi-Abad S
    BMC Infect Dis; 2020 Oct; 20(1):736. PubMed ID: 33028232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors.
    Slot E; Janssen MP; Marijt-van der Kreek T; Zaaijer HL; van de Laar TJ
    Transfusion; 2016 Jan; 56(1):203-14. PubMed ID: 26355711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study.
    Farshadpour F; Taherkhani R; Tajbakhsh S; Gholizadeh Tangestani M; Hajiani G; Sharifi N; Taherkhani S; Nejadbolkheyr A
    PLoS One; 2016; 11(6):e0157615. PubMed ID: 27309959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing blood transfusion safety using molecular detection in the country of Georgia.
    Alkhazashvili M; Bloch EM; Shadaker S; Kuchuloria T; Getia V; Turdziladze A; Armstrong PA; Gamkrelidze A
    Transfus Clin Biol; 2023 Aug; 30(3):307-313. PubMed ID: 36907246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
    Bruhn R; Lelie N; Busch M; Kleinman S;
    Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of repeat testing of living kidney donors within 14 days of the transplant procedure: a multicenter retrospective survey.
    Echenique IA; Cohen D; Rudow DL; Ison MG
    Transpl Infect Dis; 2014 Jun; 16(3):403-11. PubMed ID: 24796964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donors.
    Tafesse TB; Gebru AA; Gobalee S; Belay GD; Belew MT; Ataro D; Ebrahim BA; Shebeshi GM; Yimam Y
    Hum Antibodies; 2017; 25(1-2):39-55. PubMed ID: 28009328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood donors' positivity for transfusion-transmissible infections: the Serbian Military Medical Academy experience.
    Vučetić D; Kecman G; Ilić V; Balint B
    Blood Transfus; 2015 Oct; 13(4):569-75. PubMed ID: 26057495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting HCV and HIV seroepidemiology in 11 years of blood donors screening in Brazil.
    Levi JE; Lira SM; Bub CB; Polite MB; Terzian CC; Kutner JM
    Transfus Med; 2017 Aug; 27(4):286-291. PubMed ID: 28524366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
    CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.